<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37681523</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2024</Year><Month>04</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>146</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Can immunological imprinting drive neurological dysfunction in long COVID?</ArticleTitle><Pagination><StartPage>3960</StartPage><EndPage>3962</EndPage><MedlinePgn>3960-3962</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awad307</ELocationID><Abstract><AbstractText>This scientific commentary refers to &#x2018;Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses&#x2019; by Spatola <i>et al.</i> (https://doi.org/10.1093/brain/awad155).</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kolson</LastName><ForeName>Dennis L</ForeName><Initials>DL</Initials><Identifier Source="ORCID">0000-0002-7596-5726</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS122570</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016420">Comment</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentOn"><RefSource>Brain. 2023 Oct 3;146(10):4292-4305. doi: 10.1093/brain/awad155</RefSource><PMID Version="1">37161609</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The author reports no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>8</Day><Hour>7</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>9</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37681523</ArticleId><ArticleId IdType="pmc">PMC11004940</ArticleId><ArticleId IdType="doi">10.1093/brain/awad307</ArticleId><ArticleId IdType="pii">7263947</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Burden of Disease Long CC; Wulf Hanson &#xa0;S, Abbafati &#xa0;C, et al. &#xa0;Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021. JAMA. 2022;328:1604&#x2013;1615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9552043</ArticleId><ArticleId IdType="pubmed">36215063</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet &#xa0;M, Sillett &#xa0;R, Zhu &#xa0;Let al. &#xa0;Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: An analysis of 2-year retrospective cohort studies including 1&#x2008;284&#x2008;437 patients. Lancet Psychiatry. 2022;9:815&#x2013;827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9385200</ArticleId><ArticleId IdType="pubmed">35987197</ArticleId></ArticleIdList></Reference><Reference><Citation>Spatola &#xa0;M, Nziza &#xa0;N, Jung &#xa0;W, et al. &#xa0;Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses. Brain. 2023;146:4292&#x2013;4305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11004923</ArticleId><ArticleId IdType="pubmed">37161609</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos &#xa0;M, Ellebedy &#xa0;AH. Immunological imprinting: Understanding COVID-19. Immunity. 2023;56:909&#x2013;913.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10113596</ArticleId><ArticleId IdType="pubmed">37105169</ArticleId></ArticleIdList></Reference><Reference><Citation>Monto &#xa0;AS, Malosh &#xa0;RE, Petrie &#xa0;JG, Martin &#xa0;ET. The doctrine of original antigenic sin: Separating good from evil. J Infect Dis. &#xa0;2017;215:1782&#x2013;1788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5853211</ArticleId><ArticleId IdType="pubmed">28398521</ArticleId></ArticleIdList></Reference><Reference><Citation>Guthmiller &#xa0;JJ, Wilson &#xa0;PC. Harnessing immune history to combat influenza viruses. Curr Opin Immunol. 2018;53:187&#x2013;195.</Citation><ArticleIdList><ArticleId IdType="pubmed">29890370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou &#xa0;Z, Barrett &#xa0;J, He &#xa0;X. Immune imprinting and implications for COVID-19. Vaccines (Basel). 2023;11:875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10142218</ArticleId><ArticleId IdType="pubmed">37112787</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein &#xa0;SR, Ramelli &#xa0;SC, Grazioli &#xa0;A, et al. &#xa0;SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612:758&#x2013;763.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Eden &#xa0;A, Grahn &#xa0;A, Bremell &#xa0;D, et al. &#xa0;Viral antigen and inflammatory biomarkers in cerebrospinal fluid in patients with COVID-19 infection and neurologic symptoms compared with control participants without infection or neurologic symptoms. JAMA Netw Open. 2022;5:e2213253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9127556</ArticleId><ArticleId IdType="pubmed">35604688</ArticleId></ArticleIdList></Reference><Reference><Citation>Barzegar &#xa0;M, Houshi &#xa0;S, Sadeghi &#xa0;E, et al. &#xa0;Association of disease-modifying therapies with COVID-19 susceptibility and severity in patients with multiple sclerosis: A systematic review and network meta-analysis. Mult Scler Int. 2022;2022:9388813.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9519336</ArticleId><ArticleId IdType="pubmed">36187599</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>